Dr Gary Pace
InvestorPartner and Investment Committee Chair at Pacific Channel
La Jolla, California, USA
About
Gary Pace is an entrepreneur and operations manager in life sciences with over 40 years of experience developing and commercializing technologies across biotechnology, pharmaceuticals, medical devices, and food. He holds a B.Sc. (Hons I) from the University of New South Wales and a Ph.D. from MIT, where he was a Fulbright Fellow, and is an elected Fellow of the Australian Academy of Technological Sciences and Engineering. He has held visiting academic roles at MIT and the University of Queensland and served as a director of ResMed Inc from 1994 to 2018.
Invests in
BiotechFoodTechMedical Devices
Investments
Board seats
Antisense TherapeuticsCardiff OncologyEngender TechnologiesInsituGenPacira Pharmaceuticals IncSimavita LtdSomnaceuticsUpstream Medical Technologies
Per the firm's website.
Colleagues at Pacific Channel
Frequently asked questions
- Who is Dr Gary Pace?
- Gary Pace is an entrepreneur and operations manager in life sciences with over 40 years of experience developing and commercializing technologies across biotechnology, pharmaceuticals, medical devices, and food. He holds a B.Sc. (Hons I) from the University of New South Wales and a Ph.D. from MIT, where he was a Fulbright Fellow, and is an elected Fellow of the Australian Academy of Technological Sciences and Engineering. He has held visiting academic roles at MIT and the University of Queensland and served as a director of ResMed Inc from 1994 to 2018.
- Where does Dr Gary Pace work?
- Dr Gary Pace is Partner and Investment Committee Chair at Pacific Channel.
- What does Dr Gary Pace invest in?
- Dr Gary Pace invests in Biotech, FoodTech, Medical Devices.
- What boards does Dr Gary Pace sit on?
- Dr Gary Pace holds tracked board seats at Antisense Therapeutics, Cardiff Oncology, Engender Technologies, InsituGen, Pacira Pharmaceuticals Inc, Simavita Ltd, Somnaceutics, Upstream Medical Technologies.